Search research articles
Contact Us
Filters
Showing results (131-140 of 190) with videos related to
Page
of 19
Sort By:
Anti-Cancer Drugs
|
May 2, 2000
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study
T Ruotsalainen, M Halme, O P Isokangas, et al.
Anti-Cancer Drugs
|
December 1, 1992
Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines
A M Hand, K Husgafvel-Pursiainen, K Pelin, et al.
Clinical Immunology and Immunopathology
|
October 1, 1986
Interferon-mediated in vivo induction of beta 2-microglobulin on small-cell lung cancers and mid-gut carcinoids
K Funa, A F Gazdar, K Mattson, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2003
Differentially functionalized diamines as novel ligands for the NPY2 receptor
Charles J Andres, Ildiko Antal Zimanyi, Milind S Deshpande, et al.
International Journal of Cancer
|
March 17, 2001
Gene expression profiling of malignant mesothelioma cell lines: cDNA array study
E Kettunen, A M Nissén, T Ollikainen, et al.
Cancer Genetics and Cytogenetics
|
September 1, 1992
Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies
M Tiainen, A Hopman, O Moesker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
K Mattson, G Giaccone, A Kirkpatrick, et al.
Cancer Genetics and Cytogenetics
|
July 1, 1996
Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization
P Kivipensas, A M Björkqvist, R Karhu, et al.
Cancer Treatment Reports
|
January 1, 1983
Complications of treatment of small cell carcinoma of the lung
M D Abeloff, J Klastersky, P D Drings, et al.
Scandinavian Journal of Work, Environment & Health
|
December 1, 1991
Relative risk of mesothelioma associated with different levels of exposure to asbestos
T Tuomi, M S Huuskonen, M Virtamo, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 190) with videos related to
Sort By:
Page
of 19
Anti-Cancer Drugs
|
May 2, 2000
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study
T Ruotsalainen, M Halme, O P Isokangas, et al.
Anti-Cancer Drugs
|
December 1, 1992
Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines
A M Hand, K Husgafvel-Pursiainen, K Pelin, et al.
Clinical Immunology and Immunopathology
|
October 1, 1986
Interferon-mediated in vivo induction of beta 2-microglobulin on small-cell lung cancers and mid-gut carcinoids
K Funa, A F Gazdar, K Mattson, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2003
Differentially functionalized diamines as novel ligands for the NPY2 receptor
Charles J Andres, Ildiko Antal Zimanyi, Milind S Deshpande, et al.
International Journal of Cancer
|
March 17, 2001
Gene expression profiling of malignant mesothelioma cell lines: cDNA array study
E Kettunen, A M Nissén, T Ollikainen, et al.
Cancer Genetics and Cytogenetics
|
September 1, 1992
Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies
M Tiainen, A Hopman, O Moesker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
K Mattson, G Giaccone, A Kirkpatrick, et al.
Cancer Genetics and Cytogenetics
|
July 1, 1996
Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization
P Kivipensas, A M Björkqvist, R Karhu, et al.
Cancer Treatment Reports
|
January 1, 1983
Complications of treatment of small cell carcinoma of the lung
M D Abeloff, J Klastersky, P D Drings, et al.
Scandinavian Journal of Work, Environment & Health
|
December 1, 1991
Relative risk of mesothelioma associated with different levels of exposure to asbestos
T Tuomi, M S Huuskonen, M Virtamo, et al.
Page
of 19